Provigil® (Modafinil) Linked to Serious Skin Reactions

Provigil® (Modafinil): The FDA has been monitoring cases of serious skin reactions, including erythema multiforme (EM), Stevens Johnson Syndrome (SJS), and toxic epidermal necrolysis (TEN) in its postmarketing reviews of adverse event reports associated with the use of modafinil (marketed as Provigil®), which has been available since 1998. Modafinil is a memory-improving and mood-brightening psychostimulant used to treat patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder.

If you or someone you know has taken Provigil® (Modafinil) and experienced serious skin reactions such as Stevens Johnson Syndrome (SJS) or toxic epidermal necrolysis (TEN), please use this form below to contact our law firm.